To further explore the functional significance of the miR-511-5p/VEGFA axis in the pro-tumor role of LINC00173.v1 in lung cancer, bevacizumab, a recombinant VEGF monoclonal antibody, was first used in a xenograft model of the mice. The gene discussed is VEGFA; the disease is lung cancer.